George Cholankeril

5.8k total citations · 2 hit papers
145 papers, 4.0k citations indexed

About

George Cholankeril is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, George Cholankeril has authored 145 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Epidemiology, 92 papers in Hepatology and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in George Cholankeril's work include Liver Disease Diagnosis and Treatment (107 papers), Liver Disease and Transplantation (72 papers) and Hepatitis C virus research (30 papers). George Cholankeril is often cited by papers focused on Liver Disease Diagnosis and Treatment (107 papers), Liver Disease and Transplantation (72 papers) and Hepatitis C virus research (30 papers). George Cholankeril collaborates with scholars based in United States, United Kingdom and Canada. George Cholankeril's co-authors include Aijaz Ahmed, Donghee Kim, Eric R. Yoo, Andrew A. Li, Brandon J. Perumpail, Muhammad Ali Khan, Stephen A. Harrison, Zobair M. Younossi, Sanjaya K. Satapathy and Chiranjeevi Gadiparthi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

George Cholankeril

137 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

2017 550 citations Brandon J. Perumpail, Eric R. Yoo et al. profile →
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

2024 61 citations Fasiha Kanwal, Jennifer R. Kramer et al. JAMA Internal Medicine profile →

Peers

Countries citing papers authored by George Cholankeril

Since Specialization

Citations

This map shows the geographic impact of George Cholankeril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Cholankeril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Cholankeril more than expected).

Fields of papers citing papers by George Cholankeril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Cholankeril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Cholankeril. The network helps show where George Cholankeril may publish in the future.

Co-authorship network of co-authors of George Cholankeril

This figure shows the co-authorship network connecting the top 25 collaborators of George Cholankeril. A scholar is included among the top collaborators of George Cholankeril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Cholankeril. George Cholankeril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in Mortality From Chronic Liver Disease Before, During, and After the COVID-19 Pandemic, 2015 to 2023 2025 ·Annals of Internal Medicine ·Donghee Kim, Pojsakorn Danpanichkul, (unknown), George Cholankeril, (unknown)	5
2	Association of High‐Sensitivity Troponins in Metabolic Dysfunction‐Associated Steatotic Liver Disease With All‐Cause and Cause‐Specific Mortality 2025 ·Alimentary Pharmacology & Therapeutics ·Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed	0
3	The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023” 2025 ·Clinical and Molecular Hepatology ·Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed	1
4	Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023 2024 ·Clinical and Molecular Hepatology ·Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed	20
5	2 ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) 2024 ·Gastroenterology ·Fasiha Kanwal, Jennifer R. Kramer, Liang Li, (unknown), Yu‐Xiao Yang, (unknown), (unknown), (unknown), Roxanne Desiderio, George Cholankeril, Steven M. Asch, Hashem B. El‐Serag	2
6	Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan 2024 ·European Journal of Nutrition ·Donghee Kim, Brandon J. Perumpail, George Cholankeril, Aijaz Ahmed	8
7	GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease breakdown → 2024 ·JAMA Internal Medicine ·Fasiha Kanwal, Jennifer R. Kramer, Liang Li, Yu‐Xiao Yang, (unknown), Xian Yu, (unknown), (unknown), Roxanne Desiderio, George Cholankeril, Mandeep Bajaj, Hashem B. El‐Serag, Steven M. Asch	61
8	Association between Body Fat Distribution and Nonalcoholic Fatty Liver Disease/Fibrosis Based on Race/Ethnicity 2024 ·Journal of Obesity & Metabolic Syndrome ·Donghee Kim, George Cholankeril, Aijaz Ahmed	2
9	Types of Physical Activity in Nonalcoholic Fatty Liver Disease and All-Cause and Cardiovascular Mortality 2023 ·Journal of Clinical Medicine ·Donghee Kim, Karn Wijarnpreecha, Brittany B. Dennis, George Cholankeril, Aijaz Ahmed	7
10	Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis 2023 ·Journal of Affective Disorders ·Donghee Kim, Brittany B. Dennis, George Cholankeril, Aijaz Ahmed	18
11	Trends in mortality of liver cancer before and during the COVID‐19 pandemic, 2017–2021 2023 ·Liver International ·Donghee Kim, (unknown), George Cholankeril, Aijaz Ahmed	4
12	Transplanting hepatitis B surface antigen–positive livers in the United States: Outcomes and opportunities 2023 ·American Journal of Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), Donghee Kim, Aijaz Ahmed, Carl L. Berg, Susanna Naggie, Fasiha Kanwal, George Cholankeril, (unknown)	5
13	Cost of Care for Patients With Cirrhosis 2023 ·The American Journal of Gastroenterology ·Fasiha Kanwal, Richard E. Nelson, Yan Liu, Jennifer R. Kramer, Rubén Hernáez, George Cholankeril, Abbas Rana, Avegail Flores, Donna L. Smith, Yumei Cao, Bettina M. Beech, Steven M. Asch	7
14	Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era 2022 ·Clinical Gastroenterology and Hepatology ·(unknown), (unknown), (unknown), Nicole E. Rich, Jihane N. Benhammou, (unknown), Donghee Kim, Aijaz Ahmed, John A. Goss, Abbas Rana, Amit G. Singal, Fasiha Kanwal, George Cholankeril	3
15	Association of Digestive Symptoms and Hospitalization in Patients With SARS-CoV-2 Infection 2020 ·The American Journal of Gastroenterology ·George Cholankeril, Alexander Podboy, (unknown), Edward A. Pham, Sean P. Spencer, Donghee Kim, Aijaz Ahmed	41
16	Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease 2019 ·Journal of Palliative Medicine ·Adeyinka Adejumo, Donghee Kim, Umair Iqbal, Eric R. Yoo, Brian C. Boursiquot, George Cholankeril, Robert J. Wong, Paul Y. Kwo, Aijaz Ahmed	16
17	Trends in hospitalizations for chronic liver disease‐related liver failure in the United States, 2005‐2014 2019 ·Liver International ·Donghee Kim, George Cholankeril, Andrew A. Li, Won Kim, Sean Tighe, Bilal Hameed, Paul Y. Kwo, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed	35
18	Disparities in mortality for chronic liver disease among Asian subpopulations in the United States from 2007 to 2016 2018 ·Journal of Viral Hepatitis ·Andrew A. Li, Donghee Kim, Won Kim, (unknown), (unknown), George Cholankeril, Ira M. Jacobson, Zobair M. Younossi, Aijaz Ahmed	13
19	Changing Trends in Etiology‐Based and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States 2018 ·Hepatology ·Donghee Kim, Andrew A. Li, Brandon J. Perumpail, Chiranjeevi Gadiparthi, Won Kim, George Cholankeril, Jeffrey S. Glenn, Stephen A. Harrison, Zobair M. Younossi, Aijaz Ahmed	146
20	Underutilization of Living Donor Liver Transplantation in the United States: Bias against MELD 20 and Higher 2016 ·Journal of Clinical and Translational Hepatology ·Ryan B. Perumpail, Eric R. Yoo, George Cholankeril, (unknown), (unknown), Waldo Concepción, Clark A. Bonham, Zobair M. Younossi, Robert J. Wong, Aijaz Ahmed	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact